GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears
New York, Jan 13, 2026, 14:49 EST — Regular session Shares of GeneDx Holdings Corp dropped roughly 8.7% to $108.90 Tuesday afternoon, continuing their slide after the genetic testing firm revealed its 2026 revenue forecast the previous day. (Yahoo) The drop is significant since GeneDx is now viewed as a high-expectations play: investors are swift to punish results that merely…